Montage Laboratories Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 3.26 Cr
as on 11-07-2024
- Paid Up Capital ₹ 3.26 Cr
as on 11-07-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 70.40 Cr
as on 11-07-2024
- Revenue 35.38%
(FY 2022)
- Profit 144.90%
(FY 2022)
- Ebitda 763.57%
(FY 2022)
- Net Worth 4.48%
(FY 2022)
- Total Assets -26.61%
(FY 2022)
About Montage Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.26 Cr and a paid-up capital of Rs 3.26 Cr.
The company has closed loans amounting to ₹70.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shripal Shah, Shrenik Shah, Kantilal Shah, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ1988PTC010867
- Company No.
010867
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 1988
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationHimatnagar, Gujarat
- Telephone
- Email Address
- Website
- Social Media
What products or services does Montage Laboratories Private Limited offer?
Montage Laboratories Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Montage Laboratories?
Board Members(7)
Financial Performance and Corporate Structure Insights of Montage Laboratories.
Montage Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.38% increase. The company also saw a substantial improvement in profitability, with a 144.9% increase in profit. The company's net worth moved up by a moderate rise of 4.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Montage Laboratories?
In 2022, Montage Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
4 years 11 months 
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Sep 2020 | ₹5.40 Cr | Satisfied |
Others Creation Date: 23 Feb 2017 | ₹33.60 Cr | Satisfied |
Others Creation Date: 30 Dec 2016 | ₹28.20 Cr | Satisfied |
How Many Employees Work at Montage Laboratories?
Montage Laboratories has a workforce of 147 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 17, 2021, Montage Laboratories has raised a total of ₹ 60.3 Cr, with the most recent deal valued at ₹ 50 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
